Loading…
Boston Scientific announced an agreement to acquire Devoro Medical, developer of the WOLF Thrombectomy Platform, for an upfront payment of approximately $269 million for the 84% stake not yet owned, plus up to $67 million in milestones.
“Today, Boston Scientific Corporation (NYSE: BSX) announced an agreement to acquire Devoro Medical, Inc., developer of the WOLF Thrombectomy® Platform.”news.bostonscientific.com
Summarized from public sources; check the original articles before acting on it.